A new protein discovered by Sheffield Researchers could suppress kidney cancer.
Dr Maria Fragiadaki and Dr Martin Zeidler from Dept of Infection, Immunity and Cardiovascular Disease and Bateson Centre at the University of Shefffield investigated proteins ankyrin repeat and single KH domain 1 (ANKHD1).
They found that ANKHD1 exists in a large number of kidney cancer patients and showed that ANKHD1 interacts with micro RNA.
Dr Maria Fragiadaki said: “What would really interest me is if we find a specific microRNA target, which we could trial on patients with kidney cancer’
MicroRNAs are currently being developed for treat several cancers including leukemias.
Ribonucleic acid (RNA) acts as a messenger to carry instructions to build proteins while Micro RNAs switches the production of RNA on or off.
Kidney cancer is the seventh most common adulthood cancer in the UK with around 12,500 new cases each year.